Efficacy and safety of pegylated IFN alfa 2b alone or in combination with ribavirin in thalassemia major with chronic hepatitis C

Ajit Sood; Praveen Sobti; Vandana Midha; Dinesh Singla; Amarjeet Kaur; Sandeep Kaushal; Neena Sood; Rasham Mittal; Sandeep Puri

首页> 外文期刊>Indian Journal of Gastroenterology >Efficacy and safety of pegylated IFN alfa 2b alone or in combination with ribavirin in thalassemia major with chronic hepatitis C

【24h】

Efficacy and safety of pegylated IFN alfa 2b alone or in combination with ribavirin in thalassemia major with chronic hepatitis C

机译：聚乙二醇干扰素α2b单独或与利巴韦林联用对慢性丙型肝炎重型地中海贫血的疗效和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Treatment of HCV infection in patients with thalassemia major (TM) is limited by the lack of large clinical trials and concerns about ribavirin-induced hemolysis.

机译：背景缺乏重型临床试验和对利巴韦林引起的溶血的担忧限制了重型地中海贫血（TM）患者的HCV感染的治疗。

著录项

来源
《Indian Journal of Gastroenterology》 |2010年第2期|p.62-65|共4页
作者
Ajit Sood; Praveen Sobti; Vandana Midha; Dinesh Singla; Amarjeet Kaur; Sandeep Kaushal; Neena Sood; Rasham Mittal; Sandeep Puri;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Blood transfusion; hemolysis;

机译：输血;溶血;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of pegylated IFN alfa 2b alone or in combination with ribavirin in thalassemia major with chronic hepatitis C [J] . Ajit Sood · Praveen Sobti · Vandana Midha · Dinesh Singla · Amarjeet Kaur · Sandeep Kaushal ·Neena Sood · Rasham Mittal · Sandeep Puri Indian journal of gastroenterology . 2010,第March期

机译：聚乙二醇干扰素α2b单独或与利巴韦林联用对慢性丙型肝炎重型地中海贫血的疗效和安全性
2. Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b [J] . Tomasz H. Mach, Andrzej Cie?la, Wioleta Warunek, Polish Archives of Internal Medicine . 2011,第12期

机译：聚乙二醇干扰素α-2a或α-2b联合利巴韦林治疗丙型肝炎病毒基因型1b引起的慢性肝炎的疗效
3. Efficacy and safety of pegylated interferon Alfa-2a or Alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: A systematic review and meta-analysis [J] . DruytsE., ThorlundK., WuP., Clinical infectious diseases . 2013,第7期

机译：聚乙二醇干扰素Alfa-2a或Alfa-2b联合利巴韦林治疗儿童和青少年慢性丙型肝炎的疗效和安全性：系统评价和荟萃分析
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNα2a shows earlier viral decline than peg-IFNα2b in combination therapy with ribavirin [O] . Tatsuya Fujino, Makoto Nakamuta, Yoko Aoyagi, 2011

机译：基因型1b慢性丙型肝炎患者病毒血症的早期动态：与利巴韦林联合治疗时peg-IFNα2a的病毒下降比peg-IFNα2b的病毒下降更早
7. PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients: A Within Trial Analysis from the Perspective of the Scottish National Health Service (NHS) [O] . Nikoglou E., Humphreys S., El khoury A., 2011

机译：PIN50 Boceprevir与聚乙二醇干扰素-Alfa和Ribavirin联合治疗基因型1型慢性丙型肝炎患者的临床疗效和成本效益：从苏格兰国家卫生服务局（NHS）的角度进行试验分析

Efficacy and safety of pegylated IFN alfa 2b alone or in combination with ribavirin in thalassemia major with chronic hepatitis C

摘要

著录项

相似文献

相关主题

期刊订阅